Vor Biopharma (VOR) Accumulated Depreciation (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Accumulated Depreciation data on file, last reported at $53000.0 in Q1 2026.

• On a quarterly basis, Accumulated Depreciation fell 99.56% year-over-year to $53000.0 in Q1 2026; TTM through Mar 2026 was $53000.0, a 99.56% decrease from a year earlier, with the FY2025 full-year figure at $25000.0, down 99.78% from the prior year.
• Accumulated Depreciation for Q1 2026 stood at $53000.0, up from $25000.0 in the prior quarter.
• Over the last five years, Accumulated Depreciation for VOR reached as high as $12.0 million in Q1 2025 and fell as low as $1000.0 in Q3 2025.
• Historically, Accumulated Depreciation has averaged $5.9 million across 5 years, with a median of $5.9 million in 2023.
• Across the five-year window, Accumulated Depreciation jumped 142.04% in 2022 and slumped 99.99% in 2025, its largest moves.
• Year by year, Accumulated Depreciation stood at $4.6 million in 2022, then surged by 75.51% to $8.1 million in 2023, then jumped by 38.6% to $11.2 million in 2024, then tumbled by 99.78% to $25000.0 in 2025, then jumped by 112.0% to $53000.0 in 2026.
• Per Business Quant data, the three most recent Accumulated Depreciation figures were $53000.0 in Q1 2026, $25000.0 in Q4 2025, and $1000.0 in Q3 2025.